Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$8.32 - $15.45 $6,789 - $12,607
-816 Reduced 0.85%
95,682 $833,000
Q4 2023

Feb 13, 2024

SELL
$8.79 - $11.51 $729 - $955
-83 Reduced 0.09%
96,498 $1.1 Million
Q3 2023

Nov 13, 2023

BUY
$8.25 - $11.35 $1,254 - $1,725
152 Added 0.16%
96,581 $930,000
Q2 2023

Aug 14, 2023

SELL
$10.1 - $11.6 $199,222 - $228,810
-19,725 Reduced 16.98%
96,429 $1.03 Million
Q1 2023

May 08, 2023

SELL
$10.37 - $12.56 $1,182 - $1,431
-114 Reduced 0.1%
116,154 $1.22 Million
Q4 2022

Feb 14, 2023

SELL
$9.9 - $12.43 $327,878 - $411,669
-33,119 Reduced 22.17%
116,268 $1.44 Million
Q3 2022

Nov 10, 2022

SELL
$10.14 - $12.38 $464,229 - $566,781
-45,782 Reduced 23.46%
149,387 $1.55 Million
Q2 2022

Aug 12, 2022

SELL
$11.05 - $12.72 $1.01 Million - $1.16 Million
-91,560 Reduced 31.93%
195,169 $2.25 Million
Q1 2022

May 04, 2022

SELL
$10.61 - $12.88 $312,825 - $379,753
-29,484 Reduced 9.32%
286,729 $3.61 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $310,867 - $399,318
-28,625 Reduced 8.3%
316,213 $3.69 Million
Q3 2021

Nov 08, 2021

SELL
$11.92 - $13.92 $209,148 - $244,240
-17,546 Reduced 4.84%
344,838 $4.5 Million
Q2 2021

Aug 09, 2021

BUY
$10.16 - $13.11 $1.43 Million - $1.85 Million
141,199 Added 63.84%
362,384 $4.66 Million
Q1 2021

May 13, 2021

BUY
$9.04 - $11.86 $102,839 - $134,919
11,376 Added 5.42%
221,185 $2.47 Million
Q4 2020

Feb 09, 2021

SELL
$9.05 - $12.2 $784,598 - $1.06 Million
-86,696 Reduced 29.24%
209,809 $2.39 Million
Q3 2020

Nov 09, 2020

BUY
$8.99 - $10.74 $1.7 Million - $2.03 Million
188,663 Added 174.94%
296,505 $2.67 Million
Q2 2020

Aug 12, 2020

BUY
$9.14 - $11.97 $985,675 - $1.29 Million
107,842 New
107,842 $1.11 Million
Q1 2020

May 04, 2020

SELL
$8.58 - $14.01 $672,037 - $1.1 Million
-78,326 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$8.22 - $14.0 $435,339 - $741,454
-52,961 Reduced 40.34%
78,326 $1.04 Million
Q3 2019

Nov 12, 2019

SELL
$8.59 - $10.96 $13,744 - $17,536
-1,600 Reduced 1.2%
131,287 $1.13 Million
Q2 2019

Aug 16, 2019

BUY
$9.8 - $12.89 $1.3 Million - $1.71 Million
132,887 New
132,887 $1.46 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $562M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.